Elena Almagro

Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial

Michiel S. van der Heijden, Matthew D. Galsky, Yohann Loriot et al. · The Lancet Oncology · 2020 · 498 citations · Full text

Medicine, Oncology, Pharmacology +14

HSD3B1 (1245A>C) germline variant and clinical outcomes in metastatic castration-resistant prostate cancer patients treated with abiraterone and enzalutamide: results from two prospective studies

Daniel Khalaf, Isabel M. Aragón, Matti Annala et al. · Annals of Oncology · 2020 · 44 citations · Full text

Medicine, Oncology, Urology +17

Use of a tyrosine kinase inhibitor as neoadjuvant therapy for non-small cell lung cancer: A case report

Elena Almagro, Clara Salas, A. Varela et al. · Respiratory Medicine Case Reports · 2013 · 16 citations · Full text

Medicine, Oncology, Pharmacology +17

Prospective Assessment of Bone Metabolism Biomarkers and Survival in Metastatic Castration-resistant Prostate Cancer Patients Treated with Radium-223: The PRORADIUM Study

Nuria Romero-Laorden, David Lorente, Guillermo de Velasco et al. · European Urology Oncology · 2023 · 14 citations

Medicine, Oncology, Radiation Oncology +17